Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate versus azathioprine in lichen planopilaris
IRCT20191006045005N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methotrexate and azathioprine in lichen planopilaris (LPP) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Lichen planopilaris activity index score, Dermoscopy score and 1 more. Started Apr 2021; status: completed.
02
Drugs
methotrexateazathioprine
03
Conditions
lichen planopilaris (LPP)
Beyond the preview
Go deeper on IRCT20191006045005N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191006045005N2.